Delivery Order SPE2DB20D3103-SPE2DB22FN7S4
Award Date 5/27/22
Potential Completion Date 5/31/22
Potential Value $44K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,201.01 and an ultimate completion date of April 25, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,704.75 and runs through February 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order under a larger...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $62,408.54 firm fixed-price contract was awarded on June 21, 2024 to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, with a completion date of June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award, valued at $23,835.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Xifaxan 550 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide...
- The federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The $9,778.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $33,836.40 and an ultimate completion date of April 18, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not associated with a set-aside designation, indicating...
- This federal contract award is for the pharmaceutical product Xifaxan 550 mg tablets, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,969.73, was awarded by the Defense Logistics Agency (DLA) as a delivery order. It has a firm fixed price and an ultimate completion date of March 28, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,288.49 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of September 25, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). AmerisourceBergen holds a...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to support Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,791.73 and runs through March 27, 2023. It is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $56,703.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xifaxan 550 mg tablets, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for...